Whole blood donation supine
DeviceSubjects will undergo a 1-unit whole blood donation in a supine position
NCT Number: NCT05980013
The study is a prospective, non-randomized, non-blinded, non-significant risk study enrolling up to 60 healthy adult subjects consented to undergo a 1-unit whole blood draw procedure. Subjects will wear the study device (CM-1500) while positioned in either a supine or reclined position during the blood draw and study-required physiological parameters will be captured pre-, during, and post-donation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Vitalant Research Institute, Denver, Colorado, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will undergo a 1-unit whole blood donation in a supine position
Subjects will undergo a 1-unit whole blood donation in a reclined position
Time frame: Recovery period following donation (10 minutes)
The objective of this study is to determine if manual blood loss of up to 500mL of blood affects heart rate. This will be measured by determining the percent change in HR before and after the Blood Draw. The percent change will be calculated separately for each Arm (reclined, supine). Based on previous studies, a positive outcome would be indicated by an increase in HR (i.e., positive percent change).
Zynex Monitoring Solutions
Industry
Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the Zynex Cardiac Monitor, Model 1500 (CM-1500)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05705115
Fluid Loss, Hemodynamic Instability
Oslo, Norway
View Trial DetailsNCT05070819
Cardiac Disease, Cardiac Output, High
Moscow, Russia
View Trial DetailsNCT05012462
Fluid Loss
Denver, Colorado, United States
View Trial DetailsNCT05463198
Fluid Loss
Denver, Colorado, United States
View Trial Details